(Q39338815)

English

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

object named as

Stuart Peacock

11

0 references

Eduardo L. Franco

object named as

Eduardo L Franco

13

0 references

2

object named as

Mel Krajden

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

object named as

Kathy Ceballos

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Dirk van Niekerk

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Laurie W Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Darrel Cook

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Marette Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Laura Gentile

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Lovedeep Gondara

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ruth Elwood-Martin

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Gavin Stuart

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Andrew J Coldman

14

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

29 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

140

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

440-448

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

The cervical cancer epidemic that screening has prevented in the UK.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

FDA approves new upgraded Gardasil 9.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

A review of clinical trials of human papillomavirus prophylactic vaccines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Comprehensive control of human papillomavirus infections and related diseases.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Transitioning to a new era in cervical cancer screening.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Gynaecological cancer: New standard of care—HPV testing for cervical cancer screening.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30454

21 January 2018

Identifiers

10.1002/IJC.30454

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39338815&oldid=2120069575"